silybin has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Chen, L; Chen, P; Chen, S; Chen, Y; Hong, X; Huang, S; Ji, Y; Li, X; Mao, Y; Ping, Y; Shi, L; Song, Z; Sun, X; Wismeijer, D; Wu, G | 1 |
| Abboud, HE; Cavaglieri, RC; Fanti, P; Gorin, Y; Khazim, K | 1 |
2 other study(ies) available for silybin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Activation of PGC-1α-dependent mitochondrial biogenesis supports therapeutic effects of silibinin against type I diabetic periodontitis.
Topics: Animals; Diabetes Mellitus, Type 1; Humans; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Silybin; Transcription Factors; X-Ray Microtomography | 2023 |
The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Glucose; Mice; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Podocytes; Reactive Oxygen Species; Silybin; Silymarin; Superoxides | 2013 |